Ras, Raf, and MAP kinase in melanoma

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Melanoma is an aggressive skin cancer with significant molecular heterogeneity.
• Advances in understanding melanoma biology have identified critical driver mutations.
• The Ras/Raf/MAPK pathway is frequently altered in melanoma.

Purpose of the Study:

• To review the molecular biology of melanoma, focusing on key genetic mutations.
• To discuss the role of these mutations in melanoma progression and diagnosis.
• To provide an overview of targeted therapies relevant to pathologists.

Main Methods:

• Literature review of melanoma genetics and molecular mechanisms.
• Focus on mutations in BRAF, NRAS, MEK, KIT, GNAQ, and GNA11.
• Correlation of molecular findings with histopathology and clinical characteristics.

Main Results:

• Common mutations target the Ras/Raf/MAPK pathway (e.g., BRAF, NRAS, MEK).
• Other mutations (e.g., KIT, GNAQ, GNA11) are relevant in specific melanoma subtypes.
• Molecular alterations are associated with clinical and histopathologic features.

Conclusions:

• Understanding melanoma driver mutations is crucial for diagnosis and treatment.
• Targeted therapies are emerging based on specific molecular alterations.
• Pathologists play a key role in integrating molecular data into melanoma management.